Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1076)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,333
Price
$514.99
Total Value
$1.20M
Shares Held After
329,267
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,264
Price
$514.18
Total Value
$649.92K
Shares Held After
331,600
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
439
Price
$513.06
Total Value
$225.23K
Shares Held After
332,864
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
170
Price
$511.59
Total Value
$86.97K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
231
Price
$510.47
Total Value
$117.92K
Shares Held After
333,473
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$509.48
Total Value
$121.77K
Shares Held After
333,704
% of Holdings
0.1%
SeaStar Medical Holding Corp (ICU)
Messinger Michael — Chief Financial Officer
Shares
750
Price
$3.27
Total Value
$2.45K
Shares Held After
2,500
% of Holdings
30.0%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP&Chairman, Partnering
Shares
100,000
Price
$59.97
Total Value
$6.00M
Shares Held After
370,401
% of Holdings
21.3%
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$13.86
Total Value
$859.32K
Shares Held After
1,325,695
% of Holdings
4.5%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
31,801
Price
$37.18
Total Value
$1.18M
Shares Held After
18,630,739
% of Holdings
0.2%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
105,141
Price
$36.59
Total Value
$3.85M
Shares Held After
18,630,739
% of Holdings
0.6%
Invivyd, Inc. (IVVD)
Andersen Jill — Chief Legal Officer, Secretary
Shares
30,706
Price
$0.84
Total Value
$25.88K
Shares Held After
283,774
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
145
Price
$32.47
Total Value
$4.71K
Shares Held After
21,225
% of Holdings
0.7%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
2,716
Price
$32.01
Total Value
$86.93K
Shares Held After
21,370
% of Holdings
11.3%
Invivyd, Inc. (IVVD)
Duke William E. — Chief Financial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Invivyd, Inc. (IVVD)
Lee Timothy Edward — Chief Commercial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
178,937
% of Holdings
9.3%
Invivyd, Inc. (IVVD)
Allen Robert D. III — Chief Scientific Officer
Shares
17,043
Price
$0.84
Total Value
$14.37K
Shares Held After
178,765
% of Holdings
8.7%
Invivyd, Inc. (IVVD)
Green Julie — Chief Human Resources Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
242
Price
$32.47
Total Value
$7.86K
Shares Held After
25,655
% of Holdings
0.9%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
4,525
Price
$32.01
Total Value
$144.83K
Shares Held After
25,897
% of Holdings
14.9%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
637
Price
$32.47
Total Value
$20.68K
Shares Held After
124,557
% of Holdings
0.5%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
11,930
Price
$32.01
Total Value
$381.85K
Shares Held After
125,194
% of Holdings
8.7%
EyePoint, Inc. (EYPT)
Zaderej Karen L. — Director
Shares
10,600
Price
$4.93
Total Value
$52.26K
Shares Held After
49,100
% of Holdings
21.6%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$75.82
Total Value
$265.37K
Shares Held After
153,902
% of Holdings
2.2%
Verrica Pharmaceuticals Inc. (VRCA)
Rosenberg Noah L. — CMO
Shares
2,030
Price
$4.92
Total Value
$9.99K
Shares Held After
8,587
% of Holdings
23.6%
Verrica Pharmaceuticals Inc. (VRCA)
Kirby John J. — Interim CFO
Shares
5,000
Price
$4.93
Total Value
$24.65K
Shares Held After
23,962
% of Holdings
20.9%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
9,000
Price
$5.54
Total Value
$49.86K
Shares Held After
3,096,000
% of Holdings
0.3%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
10,000
Price
$11.03
Total Value
$110.30K
Shares Held After
251,000
% of Holdings
4.0%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
5,062
Price
$8.08
Total Value
$40.88K
Shares Held After
132,775
% of Holdings
3.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Kelley Shannon T — General Counsel
Shares
664
Price
$514.97
Total Value
$341.94K
Shares Held After
11,474
% of Holdings
5.5%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
29,534
Price
$76.84
Total Value
$2.27M
Shares Held After
142,265
% of Holdings
17.2%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
2,525
Price
$25.57
Total Value
$64.56K
Shares Held After
2,180,518
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
318,799
Price
$25.08
Total Value
$8.00M
Shares Held After
2,183,043
% of Holdings
12.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,500
Price
$103.48
Total Value
$776.12K
Shares Held After
767,780
% of Holdings
1.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,000
Price
$102.55
Total Value
$922.98K
Shares Held After
775,280
% of Holdings
1.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,100
Price
$101.77
Total Value
$213.71K
Shares Held After
784,280
% of Holdings
0.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
500
Price
$100.46
Total Value
$50.23K
Shares Held After
786,380
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
900
Price
$98.96
Total Value
$89.06K
Shares Held After
786,880
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
NEUPERT PETER M — Director
Shares
69,690
Price
$25.16
Total Value
$1.75M
Shares Held After
130,625
% of Holdings
34.8%
Adaptive Biotechnologies Corp (ADPT)
NEUPERT PETER M — Director
Shares
40,000
Price
$25.10
Total Value
$1.00M
Shares Held After
200,315
% of Holdings
16.6%
Adaptive Biotechnologies Corp (ADPT)
NEUPERT PETER M — Director
Shares
15,000
Price
$25.23
Total Value
$378.45K
Shares Held After
240,315
% of Holdings
5.9%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
55,016
Price
$1.50
Total Value
$82.78K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
34,020
Price
$1.49
Total Value
$50.53K
Shares Held After
48,750
% of Holdings
41.1%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
57,670
Price
$1.51
Total Value
$86.82K
Shares Held After
82,770
% of Holdings
41.1%
Replimune Group, Inc. (REPL)
Hill Emily Luisa — Chief Financial Officer
Shares
9,256
Price
$14.28
Total Value
$132.18K
Shares Held After
215,852
% of Holdings
4.1%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
18,706
Price
$6.01
Total Value
$112.39K
Shares Held After
633,867
% of Holdings
2.9%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
16,696
Price
$6.01
Total Value
$100.31K
Shares Held After
565,592
% of Holdings
2.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
969
Price
$72.90
Total Value
$70.64K
Shares Held After
105,272
% of Holdings
0.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,844
Price
$72.39
Total Value
$133.49K
Shares Held After
106,241
% of Holdings
1.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,730
Price
$26.18
Total Value
$123.83K
Shares Held After
36,475
% of Holdings
11.5%
Showing 751–800 of 1076 transactions (page 16 of 22)